Physician profile
Huy Vu
NPI 1578553392
$6,165.09
in general payments reported to CMS, 2019-2025
40 companies · $1,243 in 2025
The $1,243 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $762 · 2020: $176 · 2021: $136 · 2022: $1,068 · 2023: $1,252 · 2024: $1,527 · 2025: $1,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,022.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $907.09 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $779.53 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $749.68 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $727.53 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $381.92 | 2019-2025 | Ubrelvy, Qulipta |
| Glaxosmithkline, LLC. | $337.98 | 2022-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $260.48 | 2022-2025 | Otezla, Repatha, Repatha |
| Abbott Laboratories | $223.48 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $220.57 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Boehringer Ingelheim Pharmaceuticals, INC. | $220.55 | 2019-2025 | Jardiance |
| Exact Sciences Corporation | $159.36 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Dynavax Technologies Corporation | $119.99 | 2021-2024 | Heplisav-B |
| Biohaven Pharmaceutical Holding Company LTD. | $111.71 | 2022 | |
| Daiichi Sankyo INC. | $100.76 | 2022-2024 | Injectafer |
| Axonics, INC. | $66.56 | 2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Huy Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.